About the Neurogenetics Lab ION

At the Neurogenetics Lab, UCL Queen Square Institute of Neurology, we are dedicated to uncovering the genetic and molecular underpinnings of complex neurological and neurodevelopmental conditions. Our work spans a wide spectrum of disorders, including Parkinson’s disease, amyotrophic lateral sclerosis (ALS), ataxias, movement disorders, developmental and epileptic encephalopathies, and a broad range of rare and undiagnosed neurodevelopmental diseases.

​

We integrate genomic technologies including both short-read and long-read sequencing platforms  with advanced  analysis to identify novel disease-causing genes and to unravel the mechanisms driving disease. Our focus on multi-ethnic, globally representative populations ensures that we contribute to a more equitable and holistic understanding of the genetic architecture of neurological disease.

​

Through this integrative and inclusive approach, we aim to accelerate the path toward precision medicine, paving the way for targeted therapies and interventions that can meaningfully improve diagnosis, care, and outcomes for patients and their families around the world.